Crescentis Capital Limited Sets ₹79.62 Crore Rights Issue Terms

Crescentis Capital Limited has set the terms for a ₹79.62 crore rights issue of 1,02,08,129 equity shares at ₹78 each, with eligible shareholders entitled to receive three rights shares for every five shares held on November 4, 2026. The offer is scheduled to open on November 16 and close on November 27.

What are the terms of Crescentis Capital's rights issue?

Crescentis Capital will issue up to 1,02,08,129 fully paid-up equity shares of face value ₹10 each at an issue price of ₹78 per share. The issue price includes a premium of ₹68 per share, and the aggregate issue size is ₹79.62 crore, assuming full subscription.

The entitlement ratio is three rights equity shares for every five equity shares held by eligible shareholders on the record date. The Fund-Raising Committee fixed Wednesday, November 4, 2026, as the record date for determining shareholder eligibility. The company has also stated that rights entitlements may be renounced on-market from November 16 to November 20, 2026.

How did Crescentis Capital finalise the offer?

Crescentis Capital's Board had approved raising up to ₹80 crore through a rights issue at its September 30, 2026 meeting. At that stage, the company approved the issuance of fully paid-up rights equity shares with a face value of ₹10 each, while the price, number of shares and entitlement ratio were to be fixed later.

The company subsequently filed a Draft Letter of Offer with BSE Limited. BSE provided in-principle approval on October 23, 2026, for listing the fully paid-up equity shares proposed to be issued on a rights basis. The approval was referenced by the company as LOD/RIGHT/MV/1005/2026-27.

The Fund-Raising Committee then approved the detailed issue terms at its October 29, 2026 meeting. These terms included the ₹78 issue price, 3:5 entitlement ratio, issue size and record date. Crescentis Capital had also scheduled a Board meeting on November 3, 2026, to consider the Letter of Offer, Composite Application Form and Rights Entitlement letter.

When can shareholders apply for Crescentis Capital rights shares?

Crescentis Capital's rights issue is scheduled to open on November 16, 2026, and close on November 27, 2026. The company has indicated that allotment will be finalised by November 30, 2026, with the new shares scheduled to be listed on December 3, 2026.

Shareholders recorded as eligible on November 4 will receive rights entitlements based on the stated ratio. The offer documents set out the application process and payment mechanism. The Board's November 3 meeting was intended to approve the final Letter of Offer and related application and entitlement documentation for the issue.

Promoters Bhaskara Rao Bollineni and Bhavanam Ruthvik Reddy have confirmed that they will fully subscribe to their respective rights entitlements. They have also confirmed that they will not renounce those entitlements. This disclosure provides clarity on the promoters' stated participation in the offer but does not determine the subscription decisions of other shareholders.

How will the rights issue change Crescentis Capital's share capital?

Crescentis Capital has stated that its total equity share capital will increase from 1,70,13,549 equity shares before the issue to 2,72,21,678 equity shares after the proposed allotment. The increase corresponds to the 1,02,08,129 new equity shares offered under the rights issue.

A rights issue offers existing shareholders the opportunity to maintain their relative ownership by applying for their entitlement. Shareholders who do not apply, or who renounce their entitlement, may see their percentage holding change after the new shares are allotted. The company has provided a five-day on-market renunciation window during the subscription period.

The pricing of the issue at ₹78 per share and the entitlement ratio are the key numerical terms for investors assessing the offer. The source material does not state a specific use of proceeds for the ₹79.62 crore proposed to be raised. Therefore, the disclosed terms should be considered separately from any assessment of how the company may deploy the funds.

Why does BSE's in-principle approval matter for the offer?

BSE's October 23 in-principle approval covered the proposed listing of the fully paid-up shares to be issued through the rights offer. Crescentis Capital received this approval before the Fund-Raising Committee fixed the final price, ratio and record date on October 29.

The sequence of Board approval, draft offer filing, exchange approval and finalisation of commercial terms forms the documented process for the proposed rights issue. Crescentis Capital referred to its disclosures under the Companies Act, 2013, SEBI's Issue of Capital and Disclosure Requirements Regulations, 2018, and SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

For shareholders, the immediate dates are the November 4 record date and the November 16 to November 27 subscription period. For the company, completion of the issue remains linked to the stated allotment and listing schedule. The disclosed listing date for the new shares is December 3, 2026.

Conclusion

Crescentis Capital has converted its earlier plan to raise up to ₹80 crore into a defined ₹79.62 crore rights offer priced at ₹78 per share. The issue will add 1,02,08,129 equity shares and increase the company's total equity share count to 2,72,21,678 shares following allotment.

Shareholders should watch the issue opening on November 16, the closing date of November 27 and the scheduled allotment finalisation by November 30. The company has also scheduled listing of the rights shares for December 3, while promoter participation has been confirmed for their full rights entitlements.